These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 140525

  • 1. [Blood coagulating properties of immobilized proteases].
    Zubairov DM, Zinkevich OD.
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [Abstract] [Full Text] [Related]

  • 2. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J, Feddersen C.
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract] [Full Text] [Related]

  • 3. [Isolation and properties of acylplasmin].
    Aĭsina RB, Kazanskaia NF, Andreenko GV, Liutova LV, Pén'ia K.
    Vopr Med Khim; 1985 Aug; 31(4):30-4. PubMed ID: 2931900
    [Abstract] [Full Text] [Related]

  • 4. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Aug; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 5. [Prothrombin activation by immobilized thrombin].
    Strukova SM.
    Biokhimiia; 1976 Apr; 41(4):643-9. PubMed ID: 1022290
    [Abstract] [Full Text] [Related]

  • 6. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 7. Dose-response curves in the fibrin plate assay. Fibrinolytic acitivity of proteases.
    Haverkate F, Traas DW.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):356-65. PubMed ID: 4450190
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity of immobilized plasminogen activator.
    Senatore FF, Bernath FR.
    Res Commun Chem Pathol Pharmacol; 1985 Aug 31; 49(2):295-304. PubMed ID: 4059655
    [Abstract] [Full Text] [Related]

  • 9. [Comparative analysis of the effect of alpha-thrombin and trypsin on the state of the anticoagulating system].
    Strukova SM, Mitroshina TN, Kudriashov BA.
    Fiziol Zh SSSR Im I M Sechenova; 1983 Nov 31; 69(11):1467-72. PubMed ID: 6686161
    [Abstract] [Full Text] [Related]

  • 10. Hydrolysis of L-histidine methyl ester. II. Activity of various proteolytic enzymes with special reference to activators of human plasminogen.
    Cole ER.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):334-45. PubMed ID: 4236821
    [No Abstract] [Full Text] [Related]

  • 11. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A, Tymińska-Brzósko R.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979 Jul 31; 24():91-104. PubMed ID: 161647
    [No Abstract] [Full Text] [Related]

  • 12. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
    Janik BA, Papaioannou SE.
    Thromb Haemost; 1977 Feb 28; 37(1):154-61. PubMed ID: 576512
    [Abstract] [Full Text] [Related]

  • 13. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Feb 28; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 14. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB, Gaĭsarian ES, Snitko IaE, Varfolomeev SD.
    Bioorg Khim; 1994 Feb 28; 20(2):182-9. PubMed ID: 8155080
    [Abstract] [Full Text] [Related]

  • 15. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V, Pannell R, Broeze RJ, Mao J.
    J Clin Invest; 1988 Dec 03; 82(6):1956-62. PubMed ID: 2974047
    [Abstract] [Full Text] [Related]

  • 17. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct 03; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 18. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S.
    Cancer Res; 1981 Nov 03; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [Abstract] [Full Text] [Related]

  • 19. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF, Pandi L.
    Biochemistry; 2006 Feb 28; 45(8):2657-67. PubMed ID: 16489759
    [Abstract] [Full Text] [Related]

  • 20. [Observation of plasmin on platelet by means of thrombelastograph].
    Nishi A.
    Zasshi Tokyo Ika Daigaku; 1971 Feb 28; 29(1):1-9. PubMed ID: 4261342
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.